Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progressionEmily Van San, Tom Vanden Berghe, Vladimir A. Tyurin et al.|Cell Death and Differentiation|2023Cited by 93
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver diseaseCédric Peleman, Tom Vanden Berghe, Stig Hellemans et al.|Cell Death and Differentiation|2024Cited by 36